CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-22 | Peterson Kristine Director | Sale | −163,500 | $20.02 | $3.3M | 0 |
| 2019-02-22 | Peterson Kristine Director | Option exercise · Stock Option (Right to Buy) | −120,000 | 0 | ||
| 2019-02-22 | Peterson Kristine Director | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2019-02-22 | Peterson Kristine Director | Option exercise · Stock Option (Right to Buy) | −13,500 | 0 | ||
| 2019-02-22 | Kalb Michael Wayne SVP and CFO | Option exercise | +50,000 | $2.95 | $148K | 70,551 |
| 2019-02-22 | Kalb Michael Wayne SVP and CFO | Sale | −50,000 | $18.97 | $949K | 20,551 |
| 2019-02-22 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −50,000 | 83,000 | ||
| 2019-02-15 | Kalb Michael Wayne SVP and CFO | Sale | −25,000 | $17.58 | $440K | 20,551 |
| 2019-02-01 | THERO JOHN F President and CEO | Grant or award · Restricted Stock Units | +216,100 | 216,100 | ||
| 2019-02-01 | THERO JOHN F President and CEO | Grant or award · Stock Option (Right to Buy) | +302,500 | 302,500 | ||
| 2019-02-01 | Ketchum Steven B Chief Scientific Officer | Sale | −27,989 | $17.06 | $477K | 354,492 |
| 2019-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +38,200 | 38,200 | ||
| 2019-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +53,500 | 53,500 | ||
| 2019-02-01 | Kennedy Joseph T General Counsel | Grant or award · Restricted Stock Units | +38,200 | 38,200 | ||
| 2019-02-01 | Kennedy Joseph T General Counsel | Grant or award · Stock Option (Right to Buy) | +53,500 | 53,500 | ||
| 2019-02-01 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +38,200 | 38,200 | ||
| 2019-02-01 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (Right to Buy) | +53,500 | 53,500 | ||
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise | +120,000 | 2,237,271 | ||
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise | +119,667 | 2,356,938 | ||
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise | +123,667 | 2,480,605 |
Page 71 of 95 · 1,885 trades